Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone for acute sciatica
ACTRN12619001716156Phase 4Active, not recruiting
- Sponsor
- The University of Sydney
- Start
- Feb 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Sciatica comparing Prednisolone plus guideline-recommended advice with Placebo plus guideline-recommended advice (2 arms). Primary endpoint: Leg pain intensity at week 52. Started Feb 2021; status: active, not recruiting.
02
Drugs
prednisolone
03
Conditions
Sciatica
Beyond the preview
Go deeper on ACTRN12619001716156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001716156.